Pivotal Therapeutics OTCQXPVTTF; CSEPVO has received a notice of allowance from the U.S. Patent and Trademark Office USPTO that includes claims intended to protect VASCAZEN and its formulation in conjunction with a statin. The notice constitutes allowance ...
↧